Latest Consumer Goods Sector News

Talga Group has reported a quarter of significant commercial and regulatory progress, including its largest anode shipment, expanded product offerings, and major mining approvals in Sweden, supported by substantial capital raises and new patents.

Noumi Limited reported a 13.4% revenue increase in Q2 FY26 driven by strong growth in its Dairy and Nutritionals and Plant-based Milks segments, despite a $4.5 million operating cash outflow impacted by legal expenses. The company’s Milklab brand continues to gain traction both domestically and internationally.

Yowie Group Limited has extended the maturity of its secured working capital loan facility with Keybridge Capital Limited to March 2026 and increased the loan limit to A$2.5 million, including accrued interest.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.

Tasmea Limited has announced a fully franked ordinary dividend of AUD 0.06 per share for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 5% discount on new shares.

OMG Group has secured placement of its Blue Dinosaur products in 750 7-Eleven stores nationwide, marking a pivotal step in its multi-channel expansion strategy and following record quarterly cash receipts.

Noumi Limited has received Victorian Supreme Court approval for its $43 million class action settlement, closing a significant chapter tied to past financial restatements. The company’s insurer will cover its $11.56 million contribution, while legal costs will impact FY25 results.

Elixinol Wellness has appointed Natalie Butler as CEO and Adam Dimitropoulos as CFO, signaling a strategic push to strengthen leadership and drive growth.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.